(Q38424367)

3 September 2017

Looking to the horizon: the role of bilirubin in the development and prevention of age-related chronic diseases (English)

1 reference

3 September 2017

1

1 reference

3 September 2017

Marlies Wallner

2

1 reference

3 September 2017

Christine Mölzer

3

1 reference

3 September 2017

Silvia Gazzin

4

1 reference

3 September 2017

Andrew Cameron Bulmer

5

1 reference

3 September 2017

Claudio Tiribelli

6

1 reference

3 September 2017

Libor Vitek

7

1 reference

3 September 2017

language of work or name

English

0 references

publication date

1 July 2015

1 reference

3 September 2017

1 reference

3 September 2017

129

1 reference

3 September 2017

1

1 reference

3 September 2017

1-25

1 reference

Bilirubin-induced neurologic damage--mechanisms and management approaches.

3 September 2017

1 reference

https://api.crossref.org/works/10.1042%2FCS20140566

Unconjugated bilirubin restricts oligodendrocyte differentiation and axonal myelination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140566

Bilirubin mediated oxidative stress involves antioxidant response activation via Nrf2 pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140566

Bilirubin exhibits a novel anti-cancer effect on human adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140566

Bilirubin is an antioxidant of possible physiological importance

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140566

Bilirubin and beyond: a review of lipid status in Gilbert's syndrome and its relevance to cardiovascular disease protection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140566

The anti-mutagenic and antioxidant effects of bile pigments in the Ames Salmonella test.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140566

In vitro antioxidant capacity and antigenotoxic properties of protoporphyrin and structurally related tetrapyrroles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140566

Extracellular and intracellular anti-mutagenic effects of bile pigments in the Salmonella typhimurium reverse mutation assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140566

Bilirubin and related tetrapyrroles inhibit food-borne mutagenesis: a mechanism for antigenotoxic action against a model epoxide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140566

Structural basis of antimutagenicity of chemicals towards 4-nitroquinoline 1-oxide in Salmonella typhimurium.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140566

Experimental databases on inhibition of the bacterial mutagenicity of 4-nitroquinoline 1-oxide and cigarette smoke.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140566

Gilbert syndrome and ischemic heart disease: a protective effect of elevated bilirubin levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140566

Bilirubin chemistry and metabolism; harmful and protective aspects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140566

Gilbert syndrome, UGT1A1*28 allele, and cardiovascular disease risk: possible protective effects and therapeutic applications of bilirubin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140566

Serum bilirubin and genes controlling bilirubin concentrations as biomarkers for cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140566

Improved resistance to serum oxidation in Gilbert's syndrome: a mechanism for cardiovascular protection

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140566

Serum Bilirubin and Risk of Respiratory Disease and Death

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140566

Serum bilirubin levels in the U.S. population: gender effect and inverse correlation with colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140566

Association of SNPs in the UGT1A gene cluster with total bilirubin and mortality in the Diabetes Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140566

The role of bilirubin in diabetes, metabolic syndrome, and cardiovascular diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140566

A global view on the development of non communicable diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140566

The enzymatic formation of bilirubin

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140566

Heme oxygenase-1/carbon monoxide: from basic science to therapeutic applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140566

Bilirubin and the risk of common non-hepatic diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140566

Recent advances in bilirubin metabolism research: the molecular mechanism of hepatocyte bilirubin transport and its clinical relevance

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140566

Liver function from Y to Z

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140566

A common Dubin-Johnson syndrome mutation impairs protein maturation and transport activity of MRP2 (ABCC2).

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140566

Enterohepatic cycling of bilirubin as a cause of 'black' pigment gallstones in adult life.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140566

Identification of bilirubin reduction products formed by Clostridium perfringens isolated from human neonatal fecal flora.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140566

Antioxidant activities of bile pigments

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140566

The relationship between total bilirubin levels and total mortality in older adults: the United States National Health and Nutrition Examination Survey (NHANES) 1999-2004.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140566

Usefulness of serum bilirubin and cardiorespiratory fitness as predictors of mortality in men

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140566

Cardiovascular events as a function of serum bilirubin levels in a large, statin-treated cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140566

Serum bilirubin links UGT1A1*28 polymorphism and predicts long-term cardiovascular events and mortality in chronic hemodialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140566

Inverse associations of serum bilirubin with high sensitivity C-reactive protein, glycated hemoglobin, and prevalence of type 2 diabetes in middle-aged and elderly Japanese men and women

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140566

Circulating bilirubin and defense against kidney disease and cardiovascular mortality: mechanisms contributing to protection in clinical investigations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140566

Haem catabolism: a novel modulator of inflammation in Gilbert's syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140566

Circulating total bilirubin and risk of incident cardiovascular disease in the general population

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140566

Elevated serum bilirubin levels are inversely associated with coronary artery atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140566

Association of bilirubin with coronary artery calcification and cardiovascular events in the general population without known liver disease: the Heinz Nixdorf Recall study

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140566

The novel antidote Bezoar Bovis prevents the cardiotoxicity of Toad (Bufo bufo gargarizans Canto) Venom in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140566

Bilirubin attenuates bufadienolide-induced ventricular arrhythmias and cardiac dysfunction in guinea-pigs by reducing elevated intracellular Na(+) levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140566

Serum total bilirubin level and prevalent lower-extremity peripheral arterial disease: National Health and Nutrition Examination Survey (NHANES) 1999 to 2004.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140566

Serum total bilirubin level, prevalent stroke, and stroke outcomes: NHANES 1999-2004.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140566

Low serum bilirubin levels are independently and inversely related to impaired flow-mediated vasodilation and increased carotid intima-media thickness in both men and women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140566

Serum total bilirubin concentration is inversely correlated with Framingham risk score in Koreans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140566

Intraperitoneal bilirubin administration decreases infarct area in a rat coronary ischemia/reperfusion model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140566

Hyperbilirubinemia modulates myocardial function, aortic ejection, and ischemic stress resistance in the Gunn rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140566

Effects of total bilirubin on the prevalence of osteoporosis in postmenopausal women without potential liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140566

Bilirubin influences the clinical presentation of pre-eclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140566

Cardiovascular risk and psoriasis: beyond the traditional risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140566

Evaluation of early atherosclerosis in patients with inflammatory bowel disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140566

Atherosclerosis and osteoporosis: age-dependent degenerative processes or related entities?

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140566

Inflammation, lipid metabolism and cardiovascular risk in rheumatoid arthritis: A qualitative relationship?

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140566

Risk of Arterial Cardiovascular Diseases in Patients with Multiple Sclerosis: A Population-Based Cohort Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140566

Measures of cardiovascular risk and subclinical atherosclerosis in a cohort of women with a remote history of preeclampsia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140566

Detection of subclinical atherosclerosis and diastolic dysfunction in patients with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140566

Increased cardiovascular risk in patients with chronic obstructive pulmonary disease and the potential mechanisms linking the two conditions: a review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140566

Reduced circulating oxidized LDL is associated with hypocholesterolemia and enhanced thiol status in Gilbert syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140566

Induction of heme oxygenase-1 in vivo suppresses NADPH oxidase derived oxidative stress.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140566

A decrease in total bilirubin predicted hyper-LDL cholesterolemia in a health screening population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140566

Triglycerides: how much credit do they deserve?

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140566

Thinking beyond low-density lipoprotein cholesterol: strategies to further reduce cardiovascular risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140566

Impact of triglyceride levels beyond low-density lipoprotein cholesterol after acute coronary syndrome in the PROVE IT-TIMI 22 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140566

Remnant-like particle (RLP) cholesterol is an independent cardiovascular disease risk factor in women: results from the Framingham Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140566

Acute effect of weight loss on levels of total bilirubin in obese, cardiovascular high-risk patients: an analysis from the lead-in period of the Sibutramine Cardiovascular Outcome trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140566

Body fat percentage is a major determinant of total bilirubin independently of UGT1A1*28 polymorphism in young obese.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140566

Serum bilirubin level is inversely associated with nonalcoholic steatohepatitis in children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140566

Unconjugated bilirubin, a potent endogenous antioxidant, is decreased in patients with non-alcoholic steatohepatitis and advanced fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140566

Serum bilirubin levels are inversely associated with nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140566

Bilirubin increases insulin sensitivity in leptin-receptor deficient and diet-induced obese mice through suppression of ER stress and chronic inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140566

Disruption of adiponectin causes insulin resistance and neointimal formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140566

Higher serum bilirubin level as a protective factor for the development of diabetes in healthy Korean men: a 4 year retrospective longitudinal study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140566

Inverse association between total bilirubin and metabolic syndrome in rural korean women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140566

Plasma total bilirubin levels predict amputation events in type 2 diabetes mellitus: the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140566

Serum bilirubin levels and risk of prediabetes in young and healthy adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140566

A critical and comprehensive insight on heme oxygenase and related products including carbon monoxide, bilirubin, biliverdin and ferritin in type-1 and type-2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140566

The relationship of the anti-oxidant bilirubin with free thyroxine is modified by insulin resistance in euthyroid subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140566

Inflammation in atherosclerosis: from pathophysiology to practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140566

Complement activation and disease: protective effects of hyperbilirubinaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140566

Proinflammatory cytokines in CRP baseline regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140566

High serum bilirubin concentrations preserve coronary flow reserve and coronary microvascular functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140566

C-reactive protein and atherothrombosis—Beyond a biomarker: an actual partaker of lesion formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140566

Unconjugated bilirubin inhibits collagen induced platelet activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140566

Mean platelet volume and coronary artery disease: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140566

The effects of Gilbert's syndrome on the mean platelet volume and other hematological parameters

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140566

Relationship between serum bilirubin and coagulation test results in 1-month-old infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140566

Endothelial dysfunction over the course of coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140566

Bilirubin inhibits the TNFalpha-related induction of three endothelial adhesion molecules.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140566

Unconjugated bilirubin inhibits VCAM-1-mediated transendothelial leukocyte migration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140566

Soluble CD40 ligand and soluble P-selectin levels in Gilbert's syndrome: a link to protection against atherosclerosis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140566

Association of serum bilirubin and promoter variations in HMOX1 and UGT1A1 genes with sporadic colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140566

Essential roles of Raf/extracellular signal-regulated kinase/mitogen-activated protein kinase pathway, YY1, and Ca2+ influx in growth arrest of human vascular smooth muscle cells by bilirubin

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140566

Bilirubin: a natural inhibitor of vascular smooth muscle cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140566

Bilirubin and biliverdin treatment of atherosclerotic diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140566

Heme modulates smooth muscle cell proliferation and migration via NADPH oxidase: a counter-regulatory role for heme oxygenase system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140566

Inhibition of PTEN expression and activity by angiotensin II induces proliferation and migration of vascular smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140566

Serum total bilirubin is inversely associated with brachial-ankle pulse wave velocity in men with hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140566

Increased serum bilirubin level is related to good collateral development in patients with chronic total coronary occlusion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140566

Relationship between bilirubin concentration, coronary endothelial function, and inflammatory stress in overweight patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140566

Venous collagenosis and arteriolar tortuosity in leukoaraiosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140566

Significant association between leukoaraiosis and metabolic syndrome in healthy subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140566

Association between serum total bilirubin level and leukoaraiosis in Korean adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140566

Mean platelet volume (MPV) is associated with leukoaraiosis in the apparently healthy elderly.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140566

Tissue-specific effects of statins on the expression of heme oxygenase-1 in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140566

Statins alter the hepatobiliary transport of unconjugated and conjugated bilirubin in sandwich-cultured rat hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140566

Association of lower total bilirubin level with statin usage: the United States National Health and Nutrition Examination Survey 1999-2008.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140566

Serum bilirubin levels in familial hypercholesterolemia: a new risk marker for cardiovascular disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140566

In vitro inhibition of UDP glucuronosyltransferases by atazanavir and other HIV protease inhibitors and the relationship of this property to in vivo bilirubin glucuronidation

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140566

Gilbert syndrome and the development of antiretroviral therapy-associated hyperbilirubinemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140566

Differential body composition effects of protease inhibitors recommended for initial treatment of HIV infection: a randomized clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140566

Vivo-Morpholinos: a non-peptide transporter delivers Morpholinos into a wide array of mouse tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140566

Moderate hyperbilirubinemia improves renal hemodynamics in ANG II-dependent hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140566

Gene knockdowns in adult animals: PPMOs and vivo-morpholinos

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140566

Using genetic variation for establishing causality of cardiovascular risk factors: overcoming confounding and reverse causality

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140566

Association of SULT1A1 and UGT1A1 polymorphisms with breast cancer risk and phenotypes in Russian women

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140566

The role of estrogen in the initiation of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140566

Hormones and cardiovascular health in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140566

Associations between polymorphisms in glucuronidation and sulfation enzymes and mammographic breast density in premenopausal women in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140566

Genetic polymorphism in the conjugating enzyme UGT1A1 and the risk of head and neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140566

Micronuclei frequency in peripheral blood lymphocytes and cancer risk: evidence from human studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140566

Bilirubin UDP-glucuronosyltransferase 1A1 (UGT1A1) gene promoter polymorphisms and HPRT, glycophorin A, and micronuclei mutant frequencies in human blood

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140566

Binding of polycyclic planar mutagens to chlorophyllin resulting in inhibition of the mutagenic activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140566

Unconjugated bilirubin induces apoptosis in colon cancer cells by triggering mitochondrial depolarization

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140566

Bilirubin inhibits tumor cell growth via activation of ERK.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140566

In vitro DNA-damaging effects of intestinal and related tetrapyrroles in human cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140566

Damage to lipids, proteins, DNA, and RNA in mild cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140566

Evidence of oxidative damage in Alzheimer's disease brain: central role for amyloid beta-peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140566

Amyloid β-peptide (1-42)-induced oxidative stress in Alzheimer disease: importance in disease pathogenesis and progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140566

Increased bilirubins and their derivatives in cerebrospinal fluid in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140566

The Janus face of the heme oxygenase/biliverdin reductase system in Alzheimer disease: it's time for reconciliation

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140566

Heme oxygenase-1: transducer of pathological brain iron sequestration under oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140566

Increased plasma bilirubin in Parkinson patients on L-dopa: evidence against the free radical hypothesis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140566

Decreased serum bilirubin is associated with silent cerebral infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140566

Reduced status of plasma total antioxidant capacity in schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140566

Decreased plasma antioxidants in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140566

Tweaking the human circadian clock with light.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140566

Heme oxygenase-2 is a critical determinant for execution of an acute inflammatory and reparative response

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140566

Biomarkers and surrogate endpoints: preferred definitions and conceptual framework

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140566

Use of conventional and -omics based methods for health claims of dietary antioxidants: a critical overview.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140566

Role of B-type natriuretic peptide (BNP) and NT-proBNP in clinical routine

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140566

Clinical application of C-reactive protein for cardiovascular disease detection and prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140566

Guidance on the scientific requirements for health claims related to antioxidants, oxidative damage and cardiovascular health

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140566

Proportions, odds, and risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140566

Bilirubin, platelet activation and heart disease: a missing link to cardiovascular protection in Gilbert's syndrome?

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140566

Bilirubin, formed by activation of heme oxygenase-2, protects neurons against oxidative stress injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140566

Biliverdin reductase: a major physiologic cytoprotectant

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140566

Bilirubin benefits: cellular protection by a biliverdin reductase antioxidant cycle

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140566

Relationship between serum bilirubin and uric acid to oxidative stress markers in Italian and Czech populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140566

Enterohepatic Circulation of Bilirubin

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140566

Enterohepatic Circulation of Unconjugated Bilirubin in Man

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140566

Leukoaraiosis is a chronic atherosclerotic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140566

21 January 2018

Identifiers

DOI

10.1042/CS20140566

1 reference

3 September 2017

1 reference